Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000051797
JPRN-UMIN000051797
Not yet recruiting
未知

Systemic therapy for Unresectable Hepatocellular Carcinoma: Therapeutic Effectiveness by Treatment Modality and Optimal Drug Use Order - Systemic therapy for unresectable HCC

Japanese Red Cross Society Himeji Hospital0 sites5,000 target enrollmentAugust 2, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsnresectable hepatocellular carcinoma

Overview

Phase
未知
Intervention
Not specified
Conditions
nresectable hepatocellular carcinoma
Sponsor
Japanese Red Cross Society Himeji Hospital
Enrollment
5000
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2023
End Date
December 31, 2034
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japanese Red Cross Society Himeji Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patients who refuse to use clinical data (blood samples, imaging, pathology).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Choices of therapeutic strategies for hepatocellular carcinoma (HCC)C22.0Liver cell carcinoma
DRKS00025099Chirurgische Klinik, Universitätsmedizin Mannheim200
Active, not recruiting
Not Applicable
Behandlung des fortgeschrittenen hepatozellulären Karzinoms mit dem mTOR-Inhibitor Rapamycin (HCC-Rap-001)Treatment of advanced hepatocellular carcinoma with the mTOR-inhibitor rapamycin (HCC-Rap-001) - treatment of HCC with rapamyciAdvanced hepatocellular carcinoma (HCC)
EUCTR2004-002834-20-ATniversitätsklinik für Innere Medizin IV, Klinische Abteilung Gastroenterologie und Hepatologie30
Active, not recruiting
Not Applicable
Treatment of advanced hepatocellular carcinoma (HCC) with portal vein thrombosis by hepatic intra-arterial injection of microspheres loaded with Yttrium-90 (Thera-Sphere) - RAD-09advanced hepatocellular carcinoma (HCC) with portal vein thrombosisMedDRA version: 9.1Level: LLTClassification code 10024662MedDRA version: 9.1Level: PTClassification code 10019713
EUCTR2009-016475-29-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Completed
Not Applicable
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINE
PER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,
Completed
Phase 3
Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCCHepatocellular Carcinoma
NCT01229839Sun Yat-sen University668